Provided by Tiger Fintech (Singapore) Pte. Ltd.

CHINARES PHARMA

5.360
-0.020-0.37%
Volume:9.41M
Turnover:50.65M
Market Cap:33.67B
PE:8.14
High:5.440
Open:5.380
Low:5.360
Close:5.380
Loading ...

China Resources Pharmaceutical Group Limited's (HKG:3320) Shares May Have Run Too Fast Too Soon

Simply Wall St.
·
11 Feb

KPC Pharmaceuticals Records 46% Higher Net Attributable Profit in 2024

MT Newswires Live
·
10 Feb

China Resources Pharmaceutical's Shenzhen Listed Subsidiary Records 18% Higher Net Attributable Profit for 2024

MT Newswires Live
·
10 Feb

Jiang Zhong Pharmaceutical Logs 9% Increase in 2024 Profit

MT Newswires Live
·
27 Jan

BRIEF-China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln For Jiangzhong Pharmaceutical

Reuters
·
24 Jan

China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln for Jiangzhong Pharmaceutical

THOMSON REUTERS
·
24 Jan

China Resources Pharmaceutical Group's Subsidiary Expects Higher Attributable Profit in 2024

MT Newswires Live
·
22 Jan

China Resources Pharmaceutical- China Resources Boya Bio-Pharmaceutical Sees Net Profit Attributable for Year RMB380.00 Mln to RMB480.00 Mln

THOMSON REUTERS
·
22 Jan

Dong-E-E-Jiao to See Boost in 2024 Profit

MT Newswires Live
·
20 Jan

BRIEF-China Resources Pharmaceutical Sees FY Net Profit Attributable Of Dong-E-E-Jiao RMB1,500 Million To RMB1,600 Million

Reuters
·
17 Jan

China Resources Pharmaceutical Sees Net Profit Attributable of Dong-E-E-Jiao for Year RMB1,500 Mln to RMB1,600 Mln

THOMSON REUTERS
·
17 Jan

China Resources Pharmaceutical Sells 1.6 Billion Yuan of Three-Year Corporate Bonds

MT Newswires Live
·
15 Jan

China Resources Pharmaceutical Group to Renew Cooperation Agreements

MT Newswires Live
·
03 Jan

Does China Resources Pharmaceutical Group (HKG:3320) Have A Healthy Balance Sheet?

Simply Wall St.
·
19 Dec 2024

China Resources Pharmaceutical - Unit Acquired Additional 6.4 Mln Shares of Dong-E-E-Jiao From 8 Nov-18 Dec

THOMSON REUTERS
·
18 Dec 2024

China Resources Pharmaceutical - Unit Acquired Additional 5.0 Mln Shares of China Resources Boya Bio-Pharmaceutical From 8 Nov-18 Dec

THOMSON REUTERS
·
18 Dec 2024